# Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea

> **NCT02601963** · PHASE2 · COMPLETED · sponsor: **Vyne Therapeutics Inc.** · enrollment: 233 (actual)

## Conditions studied

- Rosacea
- Papulopustular Rosacea

## Interventions

- **DRUG:** FMX-103 1.5%
- **DRUG:** FMX-103 3%
- **DRUG:** Vehicle foam (0%)

## Key facts

- **NCT ID:** NCT02601963
- **Lead sponsor:** Vyne Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2017-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02601963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02601963, "Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02601963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*